Neohla Bio
The computed 12-month bankruptcy probability of Neohla Bio is 0.4% (very low). The 2025 annual accounts show equity of €347k and a net result of €-427k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €347k |
| Net result | €-427k |
| Active | 3 yrs |
| Locations | 1 |
Strong profile, led by solvency.
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →| Fiscal year | 2025 |
|---|---|
| Revenue | — |
| EBITDA | €-55k |
| Net profit | €-427k |
| Cash flow | €-43k |
| Staff costs | — |
| Income taxes | €-13k |
| Dividends | — |
| Total assets | €418k |
| Equity | €347k |
| Debt | €70k |
| of which ≤ 1y | €70k |
| of which > 1y | — |
| Working capital | €347k |
| Employees (FTE) | — |
| 2025 | |
|---|---|
| Current ratio | 5.94 |
| Quick ratio | 5.94 |
| Working capital ratio | 83.2% |
| Solvency | 83.2% |
| Debt / equity | 0.20 |
| Long-term debt ratio | — |
| Interest coverage | -174.88 |
| Gross margin | — |
| Net margin | — |
| ROA | -102.2% |
| ROE | -122.9% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €418k |
| Current assets | 29/58 | €418k |
| Amounts receivable within one year | 40/41 | €9k |
| Cash & bank | 54/58 | €357k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €418k |
| Equity | 10/15 | €347k |
| Contributions / capital | 10/11 | €1.24M |
| Accumulated profits (losses) | 14 | €-888k |
| Amounts payable | 17/49 | €70k |
| Amounts payable within one year | 42/48 | €70k |
| Trade debts payable within one year | 44 | €70k |
| Income statement | ||
| Gross operating margin | 9900 | €-55k |
| Operating result | 9901 | €-440k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €316 |
| Result before taxes | 9903 | €-440k |
| Income taxes | 67/77 | €-13k |
| Net result for the period | 9904 | €-427k |
| Result to be appropriated | 9905 | €-427k |
| NACE primary | 72101 |
| Legal form | Limited partnership(612) |
| Incorporation | 25-04-2023 |
| Status | Active |
| Postal code | 2600 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11303B0445/00F008 | Flanders | 2,372 m² | 1 · 792 m² | 23.9 m · 7 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
17-12-2025 Discharge granted to the board
Technical details
{
"events": [
{
"kind": "substantive_delegation",
"role": "beheerder",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Groovy.Bio CommV",
"address": null,
"country": null,
"legal_form": "CV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "beheerder",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-12-17",
"filing_date": "2025-12-05",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-10-28",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0801.148.536",
"name_full": "Neohla Bio",
"legal_form": "CV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}17-12-2025 Capital increase of €450,000
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 450000.0,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Bioqube",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "geld",
"n_shares_subscribed": 450000,
"contribution_amount_eur": 450000.0
}
],
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 450000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-12-17",
"filing_date": "2025-12-05",
"act_kind_objet": "Eigen vermogen verhoging"
},
"decision": {
"body": "beheerder",
"act_date": "2025-10-28",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2025-10-28"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0801.148.536",
"name_full": "Neohla Bio",
"legal_form": "Commanditaire Vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": null,
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}17-12-2025 Change in the board of directors
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0801.148.536",
"name_full": "NEOHLA BIO",
"legal_form": "CommV"
}
}17-12-2025 Capital increase of €450,000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 450000,
"currency": "EUR",
"after_eur": null,
"delta_eur": 450000,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-10-28",
"evidence_quote": "De uitvoering van een verhoging van het eigen vermogen van Neohla Bio als volgt: Bioqube brengt een bedrag in van 450.000 EUR (vierhonderdvijftigduizend euro) in ruil voor 450.000 aandelen.",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0801.148.536",
"name_full": "NEOHLA BIO",
"legal_form": "CommV"
}
}09-07-2025 Registered office moved from Vosselaar to Berchem
- Roekendreef 14, 2350 Vosselaar → Uitbreidingstraat 66 bus 31, 2600 Berchem
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Uitbreidingstraat 66 bus 31, 2600 Berchem",
"city": "Berchem",
"region": "vlaams_gewest",
"street": "Uitbreidingstraat",
"country": "BE",
"postcode": "2600",
"box_number": "31",
"street_number": "66",
"locality_suffix": null
},
"old_address": {
"raw": "Roekendreef 14, 2350 Vosselaar",
"city": "Vosselaar",
"region": "vlaams_gewest",
"street": "Roekendreef",
"country": "BE",
"postcode": "2350",
"box_number": null,
"street_number": "14",
"locality_suffix": null
},
"effective_date": "2025-07-01",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2025-07-01",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "algemene_vergadering",
"date": "2024-10-28",
"unanimous": true
},
"subject_company": {
"kbo": "0801.148.536",
"name_full": "Fence Bio",
"legal_form": "CV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": []
}09-07-2025 Articles of association amended — name change
Technical details
{
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2025-07-01",
"act_kind_objet": "Verhoging eigen vermogen, verplaatsing maatschappelijke zetel en naamswijziging"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2025-07-01",
"unanimous": true
},
"statute_change": {
"kinds": [
"capital_increase_cash",
"seat_region_change",
"name_change"
],
"scope": null,
"trigger": null,
"language_after": null,
"language_before": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0801.148.536",
"name_full_after": "Neoh\u00EDa B\u00EDo",
"legal_form_after": null,
"name_full_before": "Fence Bio",
"current_zetel_raw": "Roekendreef 14, 2350 Vosselaar",
"legal_form_before": "Commanditaire Vennootschap"
},
"special_mandates": [],
"articles_modified": [],
"governance_change": {
"organ_kind_after": null,
"organ_kind_before": null,
"admin_delegated_added": [
{
"name": "Bioqube Factory Project Company CommV",
"excluded_powers": []
}
],
"representation_rule_after": null,
"co_signature_threshold_eur": null,
"representation_rule_before": null
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Bioqube Factory Project Company CommV",
"person_name": null,
"org_rep_person_name": "Debora Dumont"
},
"co_filed_documents": [],
"shareholder_rights": null,
"voorwerp_change_summary": null,
"capital_structure_change": {
"operations": [
"capital_increase_cash"
],
"split_ratio": null,
"shares_after": 635000,
"shares_before": null,
"capital_after_eur": 635000.0,
"capital_before_eur": null,
"share_classes_after": []
},
"coordinated_text_lineage": {
"previous_ag_date": "2025-03-14",
"previous_mb_reference": null
}
}09-07-2025 Capital increase of €635,000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 635000,
"currency": "EUR",
"after_eur": null,
"delta_eur": 635000,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-10-28",
"evidence_quote": "De vergadering beslist tot de uitvoering van een verhoging van het eigen vermogen met een bedrag van 635 000 euro (zeshonderdvijfendertig duizend euro) in ruil voor 635.000 aandelen.",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0801.148.536",
"name_full": "FENCE BIO",
"legal_form": "CommV"
}
}09-07-2025 Registered office moved from Vosselaar to Berchem
- Roekendreef 14, 2350 Vosselaar → Uitbreidingstraat 66, 2600 Berchem
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Berchem",
"region": null,
"street": "Uitbreidingstraat",
"country": "BE",
"postcode": "2600",
"box_number": "31",
"street_number": "66"
},
"old_address": {
"city": "Vosselaar",
"region": null,
"street": "Roekendreef",
"country": "BE",
"postcode": "2350",
"box_number": null,
"street_number": "14"
},
"effective_date": "2025-03-14",
"evidence_quote": "De vergadering beslist, bij afzonderlijke stemming, de maatschappelijke zetel vanaf heden te verplaatsen naar Uitbreidingstraat 66 bus 31, 2600 Berchem."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0801.148.536",
"name_full": "FENCE BIO",
"legal_form": "CommV"
}
}09-07-2025 Capital increase of €635,000
- Inbreng in geld · Apport en numéraire
Technical details
{
"events": [
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 635000.0,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 635000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.0
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2025-07-01",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2025-07-01",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": "2024-10-28"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0801.148.536",
"name_full": "Fence Bio",
"legal_form": "Commanditaire Vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}09-07-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": true,
"seat_change": true,
"object_change": false,
"effective_date": "2025-03-14",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0801.148.536",
"name_full": "FENCE BIO",
"legal_form": "CommV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}05-03-2024 Registered office moved from Mechelen to Vosselaar
- Goswin de Stassartstraat 19, 2800 Mechelen → Roekendreef 14, 2350 Vosselaar
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Vosselaar",
"region": null,
"street": "Roekendreef",
"country": "BE",
"postcode": "2350",
"box_number": null,
"street_number": "14"
},
"old_address": {
"city": "Mechelen",
"region": null,
"street": "Goswin de Stassartstraat",
"country": "BE",
"postcode": "2800",
"box_number": null,
"street_number": "19"
},
"effective_date": "2023-08-31",
"evidence_quote": "Op 31 augustus 2023 heeft de beheerder Bioqube Factory Project Company CommV, vertegenwoordigd door haar vaste vertegenwoordiger Debora Dumont, beslist om de zetel van de Vennootschap met onmiddellijke ingang te verplaatsen naar de Roekendreef 14 te 2350 Vosselaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0801.148.536",
"name_full": "FENCE BIO",
"legal_form": "CommV"
}
}05-03-2024 Registered office moved to Vosselaar
- Roekendreef 14, 2350 Vosselaar
Technical details
{
"events": [
{
"kind": "zetel_transfer_cross_border_in",
"seat_type": "siege_social",
"new_address": {
"raw": null,
"city": "Vosselaar",
"region": "vlaams_gewest",
"street": "Roekendreef",
"country": "BE",
"postcode": "2350",
"box_number": null,
"street_number": "14",
"locality_suffix": null
},
"old_address": null,
"effective_date": "2023-08-31",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": true,
"old_address_source": "inferred",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2023-08-31",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"date": "2023-08-31",
"unanimous": true
},
"subject_company": {
"kbo": "0801.148.536",
"name_full": "Fence Bio",
"legal_form": "CV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "R\u0026S Consulting BV",
"person_name": null,
"org_rep_person_name": "Dirk Reyn",
"person_role_at_subject": null
},
"co_filed_documents": [
"exes du Moniteur belge",
"Voor-behouden aan het Belgisch Staatsblad",
"Mod DOC 19.01"
]
}27-04-2023 Incorporation of a new CommV
Technical details
{
"kind": "oprichting",
"seat": "Goswin de Stassartstraat 19, 2800 Mechelen",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0776.937.633",
"name": "Bioqube Factory Project Company CommV"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": "0776.937.633",
"holder_org_name": "Bioqube Factory Project Company CommV",
"contribution_type": "cash",
"amount_paid_in_eur": 1,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 1,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0747.784.678",
"name": "Bioqube Factory Fund I CommV"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": "0747.784.678",
"holder_org_name": "Bioqube Factory Fund I CommV",
"contribution_type": "cash",
"amount_paid_in_eur": 149999,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 149999,
"amount_subscribed_eur": 149999,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 150000,
"subject_company": {
"kbo": "0801.148.536",
"name_full": "Fence Bio",
"legal_form": "CommV"
},
"initial_directors": [],
"incorporation_date": "2023-04-17",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Neohla Bio |